SR9009 Storage and Stability: What the Research Describes

What SR9009 is, and why that matters for storage

SR9009 is a low-molecular-weight synthetic agonist of the REV-ERB nuclear receptors, the transcriptional repressors that form part of the core circadian clock. It is not a peptide. That single chemical fact changes how storage questions should be read: peptides are chains of amino acids that are usually freeze-dried into a lyophilized cake and are vulnerable to hydrolysis, oxidation, deamidation and aggregation, whereas SR9009 is supplied in research settings as a solid powder of a defined organic molecule. Stability guidance written for lyophilized peptides therefore overlaps only partially with the chemistry of a compound like SR9009, and this page keeps the two categories separate throughout.

The biology that drove interest in the molecule is circadian. Researchers reported that exhaustive exercise abolished the REV-ERB-α circadian rhythm and shifted the kynurenine pathway toward a neurotoxic profile in mice (PMID 40554695), and a separate study reported that circadian control of the secretory pathway maintains collagen homeostasis (PMID 31907414). A 2025 review discussed circadian clocks in an unsynchronised society (PMID 40389157). None of these papers addressed how the compound is stored; they establish the research context in which REV-ERB ligands are studied.

Compound-specific stability literature: what exists

Among the verified papers cited on this page, the only SR9009-specific work is an analytical chemistry paper: researchers described a quantitative method for the simultaneous detection of SR9009 and SR9011 in equine plasma using liquid chromatography–electrospray ionization–tandem mass spectrometry (PMID 35396832). The published scope of that method paper is detection and quantification in a biological matrix for testing purposes — it is not a shelf-life study of raw SR9009 powder, and this page does not present it as one.

That distinction is the honest answer to the underlying question. There is no dedicated, peer-reviewed storage-stability study of SR9009 in the citation set for this page that reports degradation rates at defined temperatures, humidity thresholds or expiry dating. Where the sections below describe refrigeration, freezing or transport, they describe general stability science and routine laboratory convention, not findings attributed to any SR9009 experiment. Anything presented as a research finding on this page carries a PubMed link in the same sentence; anything without one is general chemistry context.

Solid powder versus solution: the general principle

Across research chemicals broadly, the solid state is the more stable state. Water is a reactant as well as a solvent: once a solid is dissolved, hydrolysis, oxidation and microbial growth all become possible in ways they largely are not in a dry, sealed vial. Laboratory materials are therefore typically kept dry until the point of use, and stock solutions are treated as shorter-lived than the powder they came from. This is a general principle of pharmaceutical chemistry rather than an SR9009-specific measurement.

For peptides specifically, lyophilization removes water to produce a porous cake, and the same cake readily reabsorbs atmospheric moisture when a vial is opened in humid air. SR9009 is not lyophilized in that sense, but the moisture logic still applies to any hygroscopic solid: an unsealed container in a warm, humid room is a different chemical environment from a sealed, desiccated one. Poorly water-soluble small molecules of this type are commonly dissolved in organic co-solvents for in vitro work, and solvent choice, light exposure and container material all influence how long a prepared solution remains representative of the compound the researcher intended to study.

Refrigeration: what the convention rests on

Refrigerated storage, conventionally described as 2–8 °C, is the default for many research materials because reaction rates fall as temperature falls. This is Arrhenius behaviour, not an SR9009 result: a chemical degradation pathway that proceeds measurably at 25 °C generally proceeds far more slowly at refrigerator temperature. Certificates of analysis issued for research-use-only chemicals commonly state a recommended storage temperature and a retest date, and those statements reflect the supplier's own handling data rather than published literature.

Two practical caveats appear repeatedly in general handling documentation. First, refrigerators cycle through defrost phases and door openings, so the temperature at a shelf is not constant. Second, cold vials removed into warm air can collect condensation on and inside the container, reintroducing the water that drying was meant to exclude; the usual laboratory practice is to allow a sealed container to equilibrate to room temperature before opening. Neither point derives from an SR9009 study.

Freezing and freeze–thaw

Freezer storage, conventionally −20 °C for medium-term and −80 °C for long-term archival material, is the standard approach for solutions and reference standards in analytical laboratories. Repeated freeze–thaw cycling is treated as a variable in its own right: method-validation protocols in bioanalysis routinely examine whether an analyte survives several cycles in matrix, which is why aliquoting into single-use volumes is common practice. The equine plasma method paper (PMID 35396832) is an example of the analytical genre in which such matrix handling is characterised, though its published abstract describes the detection method itself rather than a set of storage conditions for bulk material.

For dry solids, freezing is generally uncontroversial from a chemical standpoint, but the condensation problem becomes larger: the colder the container, the more atmospheric water condenses on it when it is opened warm. General laboratory convention addresses this with desiccants, tightly sealed secondary containers and warm-up periods.

Shelf life, expiry and retest dates

"Expiry" has a specific regulatory meaning for approved medicines: it is a date supported by stability data submitted to a regulator under defined packaging and storage conditions. SR9009 is not an approved medicine in the United States or the European Union; it circulates as a research chemical, and material sold for laboratory use is labelled research-use-only and not for human or veterinary consumption. Anti-doping and equine testing programmes have treated SR9009 as a compound worth screening for, which is the reason detection methodology for it exists in the analytical literature (PMID 35396832).

Because of that status, dates printed on research-chemical containers are usually retest or recommended-use-by dates derived from supplier handling policy, not regulator-reviewed expiry dates. In the absence of a published SR9009 stability study, no defensible shelf-life number can be quoted here, and inventing one would misrepresent the literature.

Room temperature and transport

Shipping introduces the widest temperature excursions any research material experiences: parcel vehicles and mailboxes can exceed 40 °C in summer and drop below freezing in winter. General stability science treats short excursions differently from sustained exposure, since cumulative thermal load, not a single moment, drives degradation. Many solid research chemicals are shipped ambient precisely because the dry solid state tolerates brief warmth better than a solution would; aqueous or co-solvent solutions are the fragile format in transit. Again, these are generic transport principles, not SR9009 measurements.

Format-by-format summary of the general conventions

Signs of degradation: what general chemistry describes

Visual inspection is a crude screen, and the general literature on chemical stability is clear that a material can degrade substantially without any visible change. The cues described generically for research solids include discolouration relative to the original appearance, caking or clumping that suggests moisture uptake, and a solid that has become sticky or has partially liquefied. For solutions, the generic cues are cloudiness, visible particulates, precipitate at the bottom of a vial, or a colour shift. Because none of these observations are quantitative, analytical laboratories rely on chromatographic methods — the same family of techniques used in the equine plasma detection work (PMID 35396832) — to establish whether a sample still contains what it is labelled as containing.

Why handling matters for interpreting published results

Storage is not a side issue in circadian pharmacology; it is part of why results replicate or fail to. When researchers reported that exhaustive exercise abolished the REV-ERB-α rhythm and shifted kynurenine metabolism toward a neurotoxic profile in mice (PMID 40554695), or that circadian control of the secretory pathway maintained collagen homeostasis (PMID 31907414), the interpretive weight of those findings depended on reagents behaving as characterised. A 2025 review framed the broader problem of desynchronised clocks in modern life (PMID 40389157), and the analytical infrastructure for measuring REV-ERB ligands in biological samples continues to develop alongside it (PMID 35396832).

This page is for educational purposes only and is not medical advice; consult a licensed physician about any health decision. It summarises what published papers and general stability science describe, and it does not provide handling, preparation or usage instructions.

Related reading

• SR9009: what the research literature covers
• Peptide storage and stability, per the literature

References

• A quantitative method for the simultaneous detection of SR9009 and SR9011 in equine plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry (Drug Testing and Analysis, 2022)
• Exhaustive exercise abolishes REV-ERB-α circadian rhythm and shifts the kynurenine pathway to a neurotoxic profile in mice (The Journal of Physiology, 2025)
• Circadian control of the secretory pathway maintains collagen homeostasis (Nature Cell Biology, 2020)
• Rhythms under tension: Circadian clocks in an Unsynced Society (Biomedical Journal, 2025)